macula_rwe | R Documentation |
Meta-analysis of 83 studies comparing 12-month visual acuity change results in routine clinical practices of intravitreal therapy for diabetic maculaedema (DME) to the change in RCTs by pooling data published in the last decade on treated eyes of treatment effect from OS.
A dataframe with 83 rows and 13 columns. Each row represents study results, the columns are:
Used Medication
Author and year.
Number of tested eyes.
Mean Change in Visual Acuity after 12-Months. Where Visual Acuity is measured in VAR (Visual Acuity Rating) score
Standard Error of the Treatment Effect
Lower 95prc CI for TE
Upper 95prc CI for TE
Number of Patients in Study at Baseline
The mean age of patients per study
Mean Visual Acuity at Baseline. Where Visual Acuity is measured in VAR (Visual Acuity Rating) score
Mean Visual Acuity after 12 months. Where Visual Acuity is measured in VAR (Visual Acuity Rating) score
Mean Central Subfield Thickness at Baseline
Mean Central Subfield Thickness after 12 months
Mehta H, Nguyen V, Barthelmes D, Pershing S, Chi GC, Dopart P, Gillies MC. Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysis. Adv Ther. 2022 Dec;39(12):5376-5390. doi: 10.1007/s12325-022-02326-8. Epub 2022 Oct 15. PMID: 36241963; PMCID: PMC9618488.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.